Nicolas Boissel

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner et al. · New England Journal of Medicine · 2018 · 5.4K citations · Full text

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole et al. · The Lancet · 2021 · 721 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Medicine +9

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

Claude Preudhomme, C. Sagot, Nicolas Boissel et al. · Blood · 2002 · 503 citations · Full text

Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study

Giovanni Martinelli, Nicolas Boissel, Patrice Chevallier et al. · Journal of Clinical Oncology · 2017 · 437 citations · Full text

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

Nicolas Boissel, Harmony Leroy, Benoît Brethon et al. · Leukemia · 2006 · 355 citations

Ras Gene Mutations, Tumor Biology, Hematological Malignancy +11